Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-23-000181
Filing Date
2023-11-03
Accepted
2023-11-03 09:44:58
Documents
34
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q - SEPT. 30, 2023 bfnh20230930.htm   iXBRL 10-Q 345118
2 CERTIFICATION ex311.htm EX-31.1 4710
3 CERTIFICATION ex312.htm EX-31.2 4953
4 CERTIFICATION ex321.htm EX-32.1 2021
5 CERTIFICATION ex322.htm EX-32.2 1933
11 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-23-000181.txt   1550963

Data Files

Seq Description Document Type Size
6 bfnh-20230930.xsd EX-101.SCH 10763
7 bfnh-20230930_cal.xml EX-101.CAL 19373
8 bfnh-20230930_def.xml EX-101.DEF 19318
9 bfnh-20230930_lab.xml EX-101.LAB 103136
10 bfnh-20230930_pre.xml EX-101.PRE 75673
28 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20230930_htm.xml XML 107259
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 231374732
SIC: 3826 Laboratory Analytical Instruments